Clinical trial Recruiting at 2 sites Interventional Ages 12 to 60

Temporal interference stimulation for depressive disorder

Official title: Intervention Effect of Temporal Interference Stimulation (TIS) on Depressive Disorder

Run by The Second Hospital of Anhui Medical University · NCT07191392 · Data updated 2026-11-12

This test tries to see if temporal interference stimulation (TIS) can improve associative memory in adults with depressive disorder.

Quick facts

Study typeInterventional
Ages12 Years to 60 Years
SexAll
Enrollment60 (estimated)
SponsorThe Second Hospital of Anhui Medical University
Academic / other
Locations2 sites (Hefei, Anhui and 1 other locations)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedJune 2026
Study endsJune 2026
Registry record updatedMarch 10, 2026
Trial IDNCT07191392 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with DSM‑5 depressive disorder (HAMD>17, BSS>6, PHQ‑15>5), right‑handed, with at least five years of education and normal or corrected vision who can attend study visits are ideal candidates.

Probably not a fit

People with severe heart, liver, or renal disease, major neurological disorders (e.g., stroke, epilepsy), comorbid psychotic or substance‑use disorders, pregnant or breastfeeding women, or those outside the 18–65 age range are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Thirty adults with DSM‑5 diagnosed depressive disorder will receive either a 30‑minute session of temporal interference stimulation (TIS) or a sham TIS, with thirty matched healthy controls included for comparison. Participants complete neuropsychological assessments (including HAMD, HAMA, PHQ‑15, BSSI, PSQI, RRS, and others) and multimodal MRI (3D‑T1, resting‑state fMRI, and DTI) before and after the intervention. An incidental memory task using emotional pictures is used to measure associative memory changes pre‑ and post‑treatment. Clinical and imaging measures are compared between active and sham stimulation groups and against healthy controls.

Why it matters

Potential benefit: If successful, TIS could improve associative memory and related depressive symptoms and provide a noninvasive treatment option.

How similar studies have gone: TIS is a novel neuromodulation method with limited human efficacy data, although related noninvasive techniques like TMS and tDCS have shown modest benefits for depression and cognition.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* the patients were diagnosed by more than 2 psychiatrists and met the diagnostic criteria of DSM-5 for depression, and HAMD\>17, BSS\>6, PHQ-15\>5.
* the age ranged from 18 to 65 years old, and the length of education was more than 5 years.
* the visual acuity or corrected visual acuity is normal, right-handed, can cooperate with the completion of various experimental tests.

Exclusion Criteria:

* accompanied by severe somatic diseases, such as severe heart, liver, renal insufficiency and so on.
* accompanied by other neurological diseases, such as stroke, epilepsy and so on. pregnant and lactating women.
* accompanied by other mental disorders, such as drug abuse, schizophrenia, schizophrenic affective

Where it's running

  • Anhui Medical University
    Hefei, Anhui, China
    Recruiting
  • Anhui Mental Health Center
    Hefei, Anhui, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.